
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| CRE_R | 60 | 24.9% | 3.33 | 602 | 79.1% |
| SMP_L | 100 | 41.5% | -2.47 | 18 | 2.4% |
| MB_ML_R | 10 | 4.1% | 2.70 | 65 | 8.5% |
| CRE_L | 42 | 17.4% | -1.49 | 15 | 2.0% |
| MB_ML_L | 21 | 8.7% | 0.47 | 29 | 3.8% |
| LAL_R | 3 | 1.2% | 3.37 | 31 | 4.1% |
| EB | 4 | 1.7% | -2.00 | 1 | 0.1% |
| LAL_L | 1 | 0.4% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns CB1287 | % In | CV |
|---|---|---|---|---|---|
| CRE044 (R) | 4 | GABA | 20 | 10.8% | 0.4 |
| CB1287 (R) | 1 | Glu | 12 | 6.5% | 0.0 |
| CRE044 (L) | 3 | GABA | 11 | 5.9% | 0.8 |
| KCg-d (L) | 10 | ACh | 10 | 5.4% | 0.0 |
| PLP161 (R) | 2 | ACh | 7 | 3.8% | 0.7 |
| CRE107 (R) | 1 | Glu | 5 | 2.7% | 0.0 |
| AVLP032 (L) | 1 | ACh | 5 | 2.7% | 0.0 |
| CB0951 (R) | 2 | Glu | 4 | 2.2% | 0.5 |
| CB1062 (L) | 2 | Glu | 4 | 2.2% | 0.0 |
| KCg-m (R) | 4 | ACh | 4 | 2.2% | 0.0 |
| AVLP032 (R) | 1 | ACh | 3 | 1.6% | 0.0 |
| AN_multi_105 (L) | 1 | ACh | 3 | 1.6% | 0.0 |
| AVLP562 (L) | 1 | ACh | 3 | 1.6% | 0.0 |
| AVLP563 (L) | 1 | ACh | 3 | 1.6% | 0.0 |
| CB1062 (R) | 2 | Glu | 3 | 1.6% | 0.3 |
| MBON25,MBON34 (R) | 2 | Glu | 3 | 1.6% | 0.3 |
| KCg-m (L) | 3 | ACh | 3 | 1.6% | 0.0 |
| MBON20 (L) | 1 | GABA | 2 | 1.1% | 0.0 |
| MBON29 (R) | 1 | ACh | 2 | 1.1% | 0.0 |
| LHPV8a1 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| CL303 (R) | 1 | ACh | 2 | 1.1% | 0.0 |
| CRE024 (L) | 1 | Unk | 2 | 1.1% | 0.0 |
| CRE021 (L) | 1 | GABA | 2 | 1.1% | 0.0 |
| CRE004 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| PVLP138 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| CB3564 (L) | 1 | Glu | 2 | 1.1% | 0.0 |
| CL303 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| CRE004 (R) | 1 | ACh | 2 | 1.1% | 0.0 |
| AVLP562 (R) | 1 | ACh | 2 | 1.1% | 0.0 |
| CRE005 (R) | 1 | ACh | 2 | 1.1% | 0.0 |
| CRE043 (R) | 2 | GABA | 2 | 1.1% | 0.0 |
| CRE106 (R) | 2 | ACh | 2 | 1.1% | 0.0 |
| KCg-d (R) | 2 | ACh | 2 | 1.1% | 0.0 |
| CB1731 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| MBON01 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| LAL147c (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB0135 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB2369 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB3379 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| MBON30 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| SMP026 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| DNp62 (L) | 1 | 5-HT | 1 | 0.5% | 0.0 |
| SMP142,SMP145 (L) | 1 | DA | 1 | 0.5% | 0.0 |
| LAL199 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| CRE059 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| SMP178 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| PPL102 (R) | 1 | DA | 1 | 0.5% | 0.0 |
| CB0039 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| CRE075 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| MBON09 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| SMP116 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB2329 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| AOTU021 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CRE011 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| oviIN (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| AOTU022 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CB1967 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| LAL154 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| APL (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CRE048 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| DNpe053 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CL326 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| MBON25,MBON34 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| LAL100 (R) | 1 | GABA | 1 | 0.5% | 0.0 |
| DH44 (R) | 1 | Unk | 1 | 0.5% | 0.0 |
| CB1287 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| AVLP477 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| SMP165 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| MBON21 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| KCg-s2 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| AN_SMP_3 (L) | 1 | Unk | 1 | 0.5% | 0.0 |
| MBON30 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| DNp62 (R) | 1 | 5-HT | 1 | 0.5% | 0.0 |
| CB3362 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| MBON02 (R) | 1 | GABA | 1 | 0.5% | 0.0 |
| CL123,CRE061 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CRE059 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| SMP198 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| PAM12 (R) | 1 | DA | 1 | 0.5% | 0.0 |
| SMP383 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CL361 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LHPV8a1 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| PPL106 (L) | 1 | DA | 1 | 0.5% | 0.0 |
| CRE023 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| downstream partner | # | NT | conns CB1287 | % Out | CV |
|---|---|---|---|---|---|
| FB4H (R) | 1 | GABA | 21 | 10.1% | 0.0 |
| LAL159 (R) | 1 | ACh | 18 | 8.7% | 0.0 |
| FB4G (R) | 1 | Unk | 14 | 6.8% | 0.0 |
| CB1287 (R) | 1 | Glu | 12 | 5.8% | 0.0 |
| CRE004 (R) | 1 | ACh | 10 | 4.8% | 0.0 |
| FB4F_a,FB4F_b,FB4F_c (R) | 2 | 5-HT | 9 | 4.3% | 0.8 |
| CRE012 (R) | 1 | GABA | 6 | 2.9% | 0.0 |
| PLP161 (R) | 1 | ACh | 4 | 1.9% | 0.0 |
| DNp52 (R) | 1 | ACh | 4 | 1.9% | 0.0 |
| MBON20 (R) | 1 | GABA | 4 | 1.9% | 0.0 |
| CB2030 (R) | 2 | ACh | 4 | 1.9% | 0.5 |
| FB5V (R) | 4 | Glu | 4 | 1.9% | 0.0 |
| FB4I (R) | 1 | Glu | 3 | 1.4% | 0.0 |
| ATL034 (R) | 1 | Glu | 3 | 1.4% | 0.0 |
| FB1H (R) | 1 | DA | 3 | 1.4% | 0.0 |
| FB4M (R) | 2 | DA | 3 | 1.4% | 0.3 |
| LAL160,LAL161 (R) | 2 | ACh | 3 | 1.4% | 0.3 |
| KCg-m (R) | 3 | ACh | 3 | 1.4% | 0.0 |
| CRE041 (R) | 1 | GABA | 2 | 1.0% | 0.0 |
| PAM12 (R) | 1 | DA | 2 | 1.0% | 0.0 |
| FB4J (R) | 1 | Unk | 2 | 1.0% | 0.0 |
| ATL037 (R) | 1 | ACh | 2 | 1.0% | 0.0 |
| MBON21 (R) | 1 | ACh | 2 | 1.0% | 0.0 |
| CREa1A_T01 (R) | 1 | Glu | 2 | 1.0% | 0.0 |
| MBON30 (L) | 1 | Glu | 2 | 1.0% | 0.0 |
| DNp52 (L) | 1 | ACh | 2 | 1.0% | 0.0 |
| PPL108 (R) | 1 | DA | 2 | 1.0% | 0.0 |
| FB4_unclear (R) | 1 | Unk | 2 | 1.0% | 0.0 |
| CRE042 (R) | 1 | GABA | 2 | 1.0% | 0.0 |
| CRE043 (L) | 2 | GABA | 2 | 1.0% | 0.0 |
| CB0951 (R) | 2 | Glu | 2 | 1.0% | 0.0 |
| CB3379 (L) | 2 | GABA | 2 | 1.0% | 0.0 |
| CRE044 (R) | 2 | GABA | 2 | 1.0% | 0.0 |
| CRE043 (R) | 2 | GABA | 2 | 1.0% | 0.0 |
| CRE074 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SMP109 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB1251 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CRE027 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| ExR6 (R) | 1 | Unk | 1 | 0.5% | 0.0 |
| SMP157 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB1062 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| PPL103 (R) | 1 | DA | 1 | 0.5% | 0.0 |
| SMP050 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CB1064 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| PAM01 (R) | 1 | Unk | 1 | 0.5% | 0.0 |
| LAL100 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CRE075 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| CRE080c (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| SMP386 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| PAM07 (L) | 1 | DA | 1 | 0.5% | 0.0 |
| FB1H (L) | 1 | DA | 1 | 0.5% | 0.0 |
| LAL042 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| CRE045,CRE046 (R) | 1 | GABA | 1 | 0.5% | 0.0 |
| LAL160,LAL161 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LAL014 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| CRE081 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| SMP385 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| MBON03 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| CRE004 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| PPL102 (L) | 1 | DA | 1 | 0.5% | 0.0 |
| MBON25,MBON34 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| FB4Y (R) | 1 | Unk | 1 | 0.5% | 0.0 |
| CB3135 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| LAL101 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| SMP385 (R) | 1 | DA | 1 | 0.5% | 0.0 |
| SMP048 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| MBON21 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| MBON25,MBON34 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| SMP471 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| FB4H (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CRE059 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CRE022 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CRE049 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| SMP109 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CRE107 (R) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB1062 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CRE049 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| CRE045,CRE046 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CRE005 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| CRE044 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CRE005 (L) | 1 | ACh | 1 | 0.5% | 0.0 |